US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid Growth with USD 28.88 Billion Opportunity in Precision Medicine

The Global Single Cell Omics Market was valued at US$ 2.4 billion in 2022 and is projected to reach US$ 15.5 billion by 2032, growing at a CAGR of 20.2% during the forecast period.The market growth is driven by the rapid advancements in single-cell sequencing technologies, increasing investment in genomics and precision medicine, and growing applications in oncology, immunology, and neurobiology research. The rising need for high-resolution cellular analysis to understand complex biological systems is further accelerating market expansion.

The adoption of single-cell omics has revolutionized molecular biology by enabling the detailed study of individual cells' genetic, transcriptomic, proteomic, and metabolomic profiles. This capability allows researchers to uncover cellular diversity and identify novel therapeutic targets. Continuous technological innovation, integration of artificial intelligence in data interpretation, and collaborative initiatives between research institutions and biotech companies are positioning single-cell omics as a cornerstone technology in next-generation biomedical research and personalized medicine.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/single-cell-omics-market?sai-v

The Single Cell Omics Market involves advanced technologies that analyze genomes, transcriptomes, and proteomes at the single-cell level, enabling precise insights into cellular functions, disease mechanisms, and personalized medicine.

Key Developments

United States

✅ August 2025: 10x Genomics announced its plan to acquire Scale Biosciences to strengthen its single-cell analysis capabilities and expand the Chromium platform for advanced cellular profiling.

✅ March 2025: Illumina revealed its new spatial multi-omics roadmap focusing on next-generation single-cell CRISPR and spatial technologies to accelerate precision research and diagnostics.

Japan

✅ April 2025: Japan hosted the 32nd International Precision Medicine TRI-CON conference featuring dedicated sessions on single-cell multiomics, showcasing domestic advancements in microfluidic and multiplexed cell analysis platforms.

✅ March 2025: Japan's single-cell omics market recorded strong growth due to government-funded R&D and academic-industry collaborations focusing on high-throughput RNA sequencing and AI-driven biological data analysis.

Mergers and Acquisitions

United States

✅ August 2025: 10x Genomics completed the acquisition of Scale Biosciences for approximately USD 30 million, reinforcing its leadership in single-cell and spatial biology solutions.

Japan

✅ 2025: No major single-cell omics-specific mergers or acquisitions were reported, though multiple research partnerships and technology licensing agreements strengthened Japan's innovation ecosystem in the field.

Key Players:

CYTENA GmbH - US $25 million

10x Genomics - US $618 million

Becton, Dickinson and Company (BD) - US $19.4 billion

CELLENION - US $10 million

Bio-Rad Laboratories Inc. - US $2.8 billion

Mission Bio - US $50 million

Standard BioTools Inc. - US $110 million

NanoString Technologies - US $165 million

Takara Bio Inc. - US $700 million

BGI Genomics Co. - US $1.2 billion

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=single-cell-omics-market?sai-v

Market Drivers:

Rising focus on personalized medicine and precision diagnostics is fueling the adoption of single-cell omics technologies.

Increasing demand for detailed cellular-level analysis in cancer research, immunology, and neuroscience drives market growth.

Advancements in next-generation sequencing (NGS) and microfluidics enable high-throughput and cost-effective single-cell profiling.

Growing government and private funding for genomic and biomedical research supports technological innovation and expansion.

Industry Developments & Growth:

Leading players are developing integrated single-cell platforms combining genomics, transcriptomics, and proteomics for comprehensive insights.

Collaborations between academic institutions and biotech companies are accelerating R&D and clinical applications.

The market is witnessing strong growth driven by technological innovations, expanding research adoption, and increasing investment in life sciences.

Research Process:

Both primary and secondary data sources have been used in the Global Single Cell Omics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Key Segments:

➥ By Product Type: Encompasses Single-cell Genomics, Proteomics, Metabolomics, and Transcriptomics-technologies enabling detailed cellular profiling and functional insights.

➥ By Application: Extensively applied in Oncology, Cell Biology, Neurology, and Immunology for understanding disease mechanisms and developing targeted therapies.

➥ By End User: Major users include Pharmaceutical & Biotechnology Companies, Academic & Research Organizations, and Hospitals & Diagnostic Laboratories, emphasizing its role in translational and clinical research.

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/single-cell-omics-market?sai-v

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.